您当前的位置:
首页 >
文章列表页 >
Targeting vulnerable microcircuits in the ventral hippocampus of male transgenic mice to rescue Alzheimer-like social memory loss
RESEARCH | 更新时间:2025-02-24
    • Targeting vulnerable microcircuits in the ventral hippocampus of male transgenic mice to rescue Alzheimer-like social memory loss

    • Targeting vulnerable microcircuits in the ventral hippocampus of male transgenic mice to rescue Alzheimer-like social memory loss

    • “在阿尔茨海默病研究领域,这项研究阐明了背侧和腹侧海马CA1区之间不同的蛋白质和磷蛋白网络,突出了vCA1微电路对AD样tau积聚的敏感性。值得注意的是,熊果酸在减少tau负荷和靶向vCA1微电路方面的功效可能为未来治疗AD提供了一种有前景的策略。”
    • Hui-Yang Lei ,Gui-Lin Pi ,Ting He ,Rui Xiong ,Jing-Ru Lv ,Jia-Le Liu ,Dong-Qin Wu ,Meng-Zhu Li ,Kun Shi ,Shi-Hong Li ,Na-Na Yu ,Yang Gao ,Hui-Ling Yu ,Lin-Yu Wei ,Xin Wang ,Qiu-Zhi Zhou ,Pei-Lin Zou ,Jia-Yang Zhou ,Ying-Zhou Liu ,Nai-Ting Shen ,Jie Yang ,Dan Ke ,Qun Wang ,Gong-Ping Liu ,Xi-Fei Yang ,Jian-Zhi Wang ,Ying Yang
    • MMR 2025年12卷第1期 页码:48-71
    • DOI: 10.1186/s40779-024-00512-z     

      中图分类号:

    移动端阅览

  •  
  •  
  • AI导读

  • HTML全文

  • 图( 8 ) 表( 0 )

  • 参考文献

  • 出版信息

  • 数据统计

29

浏览量

38

下载量

0

CSCD

文章被引用时,请邮件提醒。
提交
工具集
  • BibTeX下载
  • Endnote下载
  • RefMan 下载
  • NoteExpress下载
  • NoteFirst下载

相关文章

E3 ubiquitin ligases in neurodegenerative diseases
Dementia in military and veteran populations: a review of risk factors—traumatic brain injury, post-traumatic stress disorder, deployment, and sleep
Engineered exosomes for diabetic foot ulcers: lessons learned, challenges remain
Bridging the lung cancer screening eligibility gap: evaluation of guideline applicability in asymptomatic patients
Frostbite: diagnosis, treatment, prognosis, and future directions

相关作者

Duan Lu Hou
Josephine Ho
Tuchen Guan
Xiao-Xue Dong
Li Zeng
Laurie H Sanders
Yun-Cheng Wu
Eng King Tan

相关机构

National Neuroscience Institute
Department of Neurology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Nanyang Technological University
Departments of Neurology and Pathology, Duke University School of Medicine
Duke Center for Neurodegeneration and Neurotherapeutics, Duke University